AMRX - Amneal Pharmaceuticals, Inc.

13.26
-0.040   -0.302%

Share volume: 2,417,557
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.31%

PREVIOUS CLOSE
CHG
CHG%
$13.30
-0.04
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
54%
Profitability 52%
Dept financing 43%
Liquidity 55%
Performance 59%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.70%
1 Month
-8.68%
3 Months
11.71%
6 Months
36.28%
1 Year
51.37%
2 Year
149.72%
Key data
Stock price
$13.26
P/E Ratio 
532.87
DAY RANGE
$13.00 - $13.29
EPS 
$0.02
52 WEEK RANGE
$6.68 - $15.42
52 WEEK CHANGE
$48.99
MARKET CAP 
3.144 B
YIELD 
N/A
SHARES OUTSTANDING 
314.363 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-05-2025
BETA 
0.91
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,297,746
AVERAGE 30 VOLUME 
$2,040,509
Company detail
CEO: Chintu Patel
Region: US
Website: amneal.com
Employees: 7,600
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products. The company operates through three segments: Generics, Specialty, and AvKARE. It sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies.

Recent news